Chantelle L. Ahlenstiel
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2.
Journal: Drug delivery and translational research
Published: December 02, 2025
Respiratory Delivery of Highly Conserved Antiviral siRNAs Suppress SARS-CoV-2 Infection.
Journal: International journal of molecular sciences
Published: October 21, 2025
Evaluation of rayleigh jet atomizer for intranasal delivery of lipid nanoparticle-siRNA formulations: stability, deposition, and device performance.
Journal: International journal of pharmaceutics
Published: May 09, 2025
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV.
Journal: Drug delivery and translational research
Published: December 24, 2024
Advances in HIV Gene Therapy.
Journal: International journal of molecular sciences
Published: November 02, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal: mBio
Published: April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal: mSphere
Published: April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal: Journal of virology
Published: April 25, 2023
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Journal: Antiviral research
Published: April 21, 2023
Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types.
Journal: Molecular pharmaceutics
Published: February 27, 2023
The interaction between Epstein-Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities.
Journal: Clinical & translational immunology
Published: February 09, 2023
Last Updated: 09/26/2026